Oncology Resource Group (ONCrg) is the competitive intelligence vendor of choice in Gliomas & Glioblastoma (GBM). Our unmatched expertise is cultivated by continuous study of the area allowing us to deliver cutting-edge reports with unparalleled depth, breadth, and insight.
Brooke Harrison, Ph.D.
Therapy Area Director
Brooke completed her post-doctoral fellowship at Stanford University after receiving her doctorate in Molecular Biology from Boston College. She has consulted with pharmaceutical and biotech companies, performing due diligence, competitive landscape analyses, and market assessments. She leverages her back- ground and knowledge of solid tumors to provide deeper analyses and insights to her clients.
Nikki Trunnell, Ph.D.
Operations Director, ONCrg
Nikki received her Ph.D. in Cancer Biology from Stanford University School of Medicine and has been supporting bio-pharmaceutical companies with her expertise in epidemiology, market forecasting, and the integration of primary and secondary research. Nikki co-manages ONCrg and serves clients through her thorough knowledge of oncology, strong scientific/clinical acumen, and command of market research and analytical method.
Pricing and More Information:
Call: 650-485-2626
Visit: www.onc-rg.com
Email: michael.reynolds@onc-rg.com
ONCrg Conference™ delivers unrivaled competitive intelligence from major congresses. ONCrg’s syndicated model covers the entire GBM landscape, but leaves room to add or drill down on your interests, so highly relevant reports are produced, including our expert opinions about the implications of new data on your pipeline.

Competitive Landscape Analysis
ONCrg Pipeline Strategies™ delivers cutting-edge profiles across the entire GBM competitive landscape, providing valuable analytics by class and treatment subset for new drugs in Phase I/II development and beyond. Reports are updated quarterly and written in two formats:
- a presentation format for higher level comparative analytics
- a corresponding compendium with additional detailed commentary from ONCrg experts
Monthly Surveillance Reports
ONCrg Sentinel™ provides vigilant monitoring of rapidly evolving scientific, clinical, and commercial activities in GBM. ONCrg experts identify and analyze events and deliver incisive commentaries to inform subscribers each month and prepare them to respond wisely to changing market conditions.
Expert Advisory Guidance
ONCrg Advisory™ is an open door to ask non-proprietary questions in GBM and your other subscription areas. Our experts utilize extensive resources and experience to provide extra guidance to inform clients’ key decisions.